Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity?
To date, hypolipidemic drugs of the statin group are among the most popular therapeutic agents used for the prevention and treatment of the most common worldwide atherosclerotic cardiovascular diseases (CVD). Therefore, considerable attention of researchers is focused on statins to study the additio...
Saved in:
| Main Authors: | A. M. Chaulin, D. V. Duplyakov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2023-05-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2764 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased level of cardiac troponin I determined by a highly sensitive method: clinical significance beyond the assessment of the severity and prognosis of acute and chronic diseases
by: I. S. Yavelov
Published: (2021-09-01) -
Perioperative assessment of troponin level in the non-cardiac interventions: is there such a need?
by: A. N. Sumin
Published: (2015-11-01) -
Evaluation of the Use of Different Sensitive Cardiac Biomarkers in Determining Myocardial Damage in Cows With Subclinical and Clinical Ketoses
by: Murat Uztimür, et al.
Published: (2025-05-01) -
A comprehensive review on the interconnection of C-reactive protein, cardiac troponins, and cytokine storm in cardiovascular manifestations of COVID-19
by: Poonam Sahu, et al.
Published: (2025-01-01) -
Troponin I – a comprehensive review of its function, structure, evolution, and role in muscle diseases
by: Dongju Han, et al.
Published: (2025-12-01)